FDA Inspection
CMIC CMO USA CorporationCMIC CMO USA Corporation – FDA Inspection, May 8, 2018
Record Details
This FDA Inspection record concerns CMIC CMO USA Corporation, with an inspection on May 8, 2018, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · b317a8a9-0eea-4f45-95ca-27a62df6938e
Inspection Facts
- Inspection number
- 1051414
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of CMIC CMO USA Corporation
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 2, 2024 | Not classified | New Jersey District Office | |
| March 31, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 4, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 11, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CMIC CMO USA Corporation
- FDA Inspection 1244346 - 2024-07-02
- FDA Inspection 1207736 - 2023-03-31
- FDA Inspection 1141200 - 2021-05-04
- FDA Inspection 1037369 - 2018-01-11
- FDA Inspection 913702 - 2015-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.